2024
|
G/S
|
Contract manufacturing in the field of pharmaceuticals
Pharmaceutical research and development; c... |
2018
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;... |
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerativ... |
2016
|
G/S
|
A patient support and adherence program, namely providing a website offering education and resour... |
|
G/S
|
Custom manufacture of pharmaceutical preparations, pharmaceutical substances and pharmaceutical d... |
2015
|
G/S
|
Payment card services; debit card services; debit account services using a computer readable card... |
|
G/S
|
Downloadable software in the nature of a mobile application for providing information on health a... |
2014
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cardiovascular disease, gastroint... |
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular disease, gastrointestinal disease... |
2013
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of: cardiovascular disease; central ... |
|
G/S
|
Pharmaceutical preparations for the prevention and/or treatment of cardiovascular disease; centra... |
2012
|
Invention
|
Sulfonyl amide derivatives for the treatment of abnormal cell growth. The present invention relat... |
|
Invention
|
H) carbaldehyde derivatives. The present invention relates to compounds and pharmaceutically acce... |
2010
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. |
|
G/S
|
Pharmaceutical preparations and substances. Medical apparatus and instruments. |
2009
|
Invention
|
Novel pyrazole compounds as transforming growth factor (tgf) inhibitors.
Novel pyrazole compound... |
|
G/S
|
Pharmaceutical preparations for the prevention and/or treatment of: cardiovascular disease; centr... |
|
G/S
|
Antibiotic preparation for human use. |
2008
|
Invention
|
Dosage forms comprising celecoxib providing both rapid and sustained pain relief. A pharmaceutica... |
|
Invention
|
1,4-dihydronaphthyridine derivatives. A compound of formulae (I) or a prodrug of the compound or ... |
|
Invention
|
Idarubicin for the treatment of lymphoma in a dog. The present invention relates to a metho... |
|
Invention
|
Idarubicin for the treatment of lymphoma in a dog. The present invention relates to a method of t... |
|
Invention
|
Multi-compartmented container. The invention provides a multi-compartmented container suitable fo... |
|
Invention
|
Polymorphs of prostaglandin agonists and methods for making the same.
The present invention rela... |
|
Invention
|
Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -ac... |
|
Invention
|
Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic ac... |
|
Invention
|
1, 3-oxazole derivatives as cetp inhibitors. Pharmaceutical compounds according to Formula I and ... |
|
Invention
|
2-[2-(4,6-dihydroxy-tetrahydro-pyran-2-yl)ethyl]-isoindole-1,3-dione and related compounds.
|
|
Invention
|
Process for preparing chiral compounds. The present invention is directed to a 2-deoxyribose-5-ph... |
|
Invention
|
Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors.
Novel fused... |
|
Invention
|
Substituted bicyclolactam compounds. The invention provides compounds of formula (1), and the pha... |
|
Invention
|
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers. A pharmaceutical co... |
|
Invention
|
Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer. A pharmaceuti... |
|
Invention
|
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrim... |
|
Invention
|
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable bloc... |
|
Invention
|
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene gly... |
|
Invention
|
Vaccine for periodontal disease.
The present invention relates to novel bacterial isolates ident... |
|
Invention
|
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polyme... |
|
Invention
|
Nanoparticles comprising a drug, ethylcellulose, and a bile salt. A pharmaceutical composition co... |
|
Invention
|
Pharmaceutical compositions comprising nanoparticles and casein. A pharmaceutical composition com... |
|
Invention
|
3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives. 8 are as defined above. The ... |
|
Invention
|
Nanoparticles comprising non-crystalline drug. A pharmaceutical composition comprises nanoparticl... |
|
Invention
|
Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] i... |
|
Invention
|
Non-anaphylactogenic ige fusion proteins.
The present invention provides compositions and method... |
|
Invention
|
Substituted oxadiazole analogs as calcium channel antagonists. This invention relates to novel co... |
|
Invention
|
Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition. This invention generall... |
|
Invention
|
Erythromycin-based macrolides. The invention relates to compounds of Formula (I) wherein R1, R2, ... |
|
Invention
|
Oxazolidinones as cholesterol absorption inhibitors. Novel oxazolidinones and pharmaceutical comp... |
|
Invention
|
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 medi... |
|
Invention
|
Tricyclic compounds and their use as glucocorticoid receptor modulators. The present invention is... |
|
Invention
|
Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof. The present inve... |
2007
|
Invention
|
Canine vaccines.
This invention relates to vaccines and methods for protecting dogs against dise... |
|
G/S
|
Pharmaceutical preparation for the treatment of cardiovascular diseases. |
|
Invention
|
Compounds having both angiotensin ii receptor antagonism and ppary activating activities.
Compou... |
|
Invention
|
Methods of vaccine administration. This invention relates to a method of treating a dog for canin... |
|
G/S
|
Pharmaceutical and veterinary preparations and substances. |
|
G/S
|
Sucker control agent for plants |
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
Invention
|
Gene predictors of response to metastatic colorectal chemotherapy.
The present invention provide... |
|
G/S
|
Pharmaceutical and veterinary preparations and substances; sanitary preparations for medical purp... |
|
Invention
|
Aminophthalazine derivative compounds.
The invention pertains to new aminophthalazine compounds ... |
2006
|
Invention
|
Pyrimidine derivatives for the treatment of abnormal cell growth. The present invention relates t... |
|
G/S
|
Pharmaceutical preparations that promote and enhance bone healing. |
|
Invention
|
Marked bovine viral diarrhea virus vaccines.
The present invention is directed to a bovine viral... |
|
G/S
|
Printed materials, namely, booklets, brochures, leaflets and pamphlets related to smoking and smo... |
|
Invention
|
Therapeutic pyrrolidines.
The present invention provides for compounds of Formula (I),
The pre... |
|
G/S
|
Apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers,... |
|
G/S
|
Inhalers for administration of pharmaceutical preparations for human use with exception of pharma... |
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. Surgical,... |
|
Invention
|
4-piperazinnylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors.
Compounds an... |
2005
|
G/S
|
Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substa... |
|
Invention
|
Dibenzyl amine compounds and derivatives.
Dibenzyl amine compounds and derivatives, pharmaceutic... |
|
Invention
|
Compositions for the treatment of inflammation and pain using a combination of a cox-2 selective ... |